CAU
BCRX icon

Caxton Associates (UK)’s BioCryst Pharmaceuticals BCRX Stock Holding History

Caxton Associates (UK)’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$254K Sell
28,379
-13,550
-32% -$121K 0.01% 575
2025
Q1 		$314K Buy
+41,929
New +$314K 0.01% 614